ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 190 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,620,987 | -18.8% | 1,214,860 | 0.0% | 1.46% | -4.3% |
Q2 2023 | $8,151,711 | -24.0% | 1,214,860 | 0.0% | 1.52% | -27.0% |
Q1 2023 | $10,727,214 | +131.0% | 1,214,860 | +99.9% | 2.09% | +95.0% |
Q4 2022 | $4,644,050 | -46.3% | 607,860 | -50.0% | 1.07% | -46.0% |
Q3 2022 | $8,650,000 | -12.0% | 1,214,860 | 0.0% | 1.98% | -13.4% |
Q2 2022 | $9,828,000 | -30.2% | 1,214,860 | +19.7% | 2.29% | -34.0% |
Q1 2022 | $14,086,000 | -33.1% | 1,014,860 | +35.2% | 3.47% | -32.4% |
Q4 2021 | $21,066,000 | +40.4% | 750,760 | +70.1% | 5.13% | +7.8% |
Q3 2021 | $15,005,000 | +42.4% | 441,466 | +71.2% | 4.76% | +31.7% |
Q2 2021 | $10,535,000 | +29.4% | 257,827 | +27.5% | 3.61% | +13.1% |
Q1 2021 | $8,141,000 | +64.8% | 202,220 | +142.1% | 3.20% | +1.1% |
Q4 2020 | $4,939,000 | – | 83,535 | – | 3.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 3,030,434 | $20,334,212 | 13.72% |
BERYLSON CAPITAL PARTNERS, LLC | 228,000 | $1,529,880 | 4.32% |
Eagle Health Investments LP | 1,214,860 | $8,151,711 | 1.52% |
Matrix Capital Management Company, LP | 11,572,590 | $77,652,079 | 0.90% |
Triatomic Management LP | 121,166 | $813,024 | 0.83% |
VIKING GLOBAL INVESTORS LP | 29,993,708 | $201,257,781 | 0.82% |
Aristotle Atlantic Partners, LLC | 3,104,961 | $20,834,288 | 0.78% |
Pier Capital, LLC | 737,589 | $4,949,222 | 0.71% |
ARK Investment Management | 10,453,752 | $70,144,675 | 0.46% |
Nikko Asset Management Americas, Inc. | 6,384,047 | $42,773,115 | 0.45% |